Objectives: To determine whether individual goal-oriented cognitive rehabilitation (CR) improves everyday functioning for people with mild-to-moderate dementia.
In CR, people with dementia, and where possible their family members or other supporters, work collaboratively with a therapist to choose personally relevant and meaningful goals relating to everyday activities. 4, 5 The therapist identifies the person's intrinsic capacity and current level of functioning, assesses the requirements of the task or activity outlined in the goal, pinpoints areas where the two are mismatched and where problems arise, and helps devise a plan to overcome these problems using evidence-based rehabilitative methods. These methods may include the use of environmental adaptations and prompts, introduction of compensatory strategies and memory aids, procedural learning of skills, and methods for learning or relearning relevant information. The personal rehabilitation plan is put into practice over several sessions, which are conducted in the home setting to ensure that changes are directly implemented in everyday situations. Progress towards attaining the identified goals is evaluated through participant-and informant-reported levels of goal attainment. 3 Early studies consistent with this approach demonstrated benefits for people with dementia. 7, 8 These were confirmed in a series of feasibility studies 9, 10 and reports from other groups, 11, 12 followed by a pilot randomised controlled trial (RCT) that demonstrated superiority over an active control condition. 13 The GREAT trial was designed to provide definitive evidence about clinical effectiveness.
| MATERIALS AND METHODS

| Design
This was a multicentre, single-blind pragmatic RCT comparing CR added to usual treatment (CR) with usual treatment alone (TAU).
Outcomes were assessed 3 and 9 months post randomisation. The trial was conducted in eight centres in England and Wales. Ethical approval was given by the Wales REC 5 National Health Service (NHS) research ethics committee (Reference 12/WA/0185). Participants and study partners provided written informed consent. The trial protocol was published, 14 and the trial was registered with Current Controlled Trials, reference ISRCTN21027481.
| Participants
Participants were people of any age with an ICD-10 diagnosis of Alzheimer, vascular or mixed dementia, and mild-to-moderate cognitive impairment as indicated by a Mini-Mental State Examination (MMSE) 15 score of 18 or above. If taking dementia-specific medication, they had to have been receiving a stable dose for at least 1 month, with no expectation of change during the trial. They had to be able to give informed consent for participation and to have a family member or other supporter ("study partner") willing to contribute.
Exclusion criteria were a prior history of stroke, brain injury, or other significant neurological disorder and, for practical reasons, inability to communicate in English. Any cases of uncertain eligibility were adjudicated by a panel of four clinicians.
| Sample size
Power calculations were based on the pilot trial. 13 To achieve 80% power to detect a medium effect size of 0.3, with alpha 0.05, in primary and secondary outcomes, for a two-sample comparison of means, we needed 175 people with dementia, together with their study partners, to complete the trial in each arm. Allowing for estimated potential attrition of 27%, we needed to randomise 480 people with dementia.
Key points
• Cognitive rehabilitation (CR) is an individualized problemsolving therapy that aims to manage or reduce functional disability by addressing personal goals selected by people with dementia in an everyday context.
• GREAT is the first large trial to show that CR improves participant and carer evaluations of everyday functioning in relation to specific, personally meaningful goals targeted in therapy.
• CR could be considered for inclusion in care pathways for people with mild-to-moderate dementia who require support to manage everyday life and to maintain engagement in activities and social participation. 
| Participant recruitment
| Randomisation and masking
Participants were individually randomised following consent and baseline assessment through secure web access to the remote randomisation centre. Randomisation was conducted by dynamic allocation 16 to protect against subversion while maintaining good balance to the 1:1 allocation ratio. Participants were stratified by centre, gender, age (under 75 vs 75 and above), and MMSE score (under 24 vs 24 and above). To maintain blinding of the trial researchers who conducted follow-up assessments, outcomes of randomisation were notified to the trial therapists only, and the trial therapists scheduled all follow-up visits by the researchers, irrespective of participants' allocation. To assess the effectiveness of blinding, at follow-up, the trial researchers indicated to which group they believed the participant was allocated.
| Intervention
The intervention consisted of 10 weekly 1-hour individual sessions of goal-oriented CR over a 3-month period followed by four 1-hour maintenance sessions over the subsequent 6 months, conducted in the participant's home. CR involved working collaboratively on up to three rehabilitation goals chosen by the participant, using a problemsolving approach. This was supplemented as needed by addressing motivational and emotional difficulties through applying emotion regulation and behavioural activation strategies, reviewing and optimising participants' existing use of strategies to manage cognitive disability, providing practice in maintaining attention and concentration, signposting to relevant services, and offering support for study partners. CR could potentially be delivered by therapists from various professional backgrounds; in this trial, the therapists were nine occupational therapists and one nurse. Therapists attended a 2-day initial training course and annual 1-day refresher training sessions and received regular centralised supervision to ensure fidelity to protocol and consistency across sites. Therapists completed therapy logs, which were reviewed by the supervisor.
| Comparator
The comparator was treatment as usual, typically consisting of medication, monitoring, and general psychosocial support.
| Outcomes
All assessments were conducted in participants' homes by trained researchers blind to group allocation.
The primary outcome was participant-rated goal attainment at 3 months, recorded using a previously validated client-centred attainment measure, a simple 0 to 10 scale that is accessible and feasible for people with cognitive impairment to complete; an improvement of 2 points in the goal attainment rating for any individual goal is considered to be clinically significant. [17] [18] [19] [20] [21] [22] Participants' individual goals were collaboratively identified through a semistructured interview, the Bangor Goal-Setting Interview (BGSI). 23 All participants chose up to three goals at baseline and rated current attainment; attainment ratings were then averaged across each participant's goals to give a single summary rating. These ratings were repeated at the 3-month followup, providing the primary outcome. Participants also rated goal attainment at 9 months, study partners independently rated participant goal attainment at 3 and 9 months, and participants rated their satisfaction with their goal attainment at 3 and 9 months.
Other secondary outcomes for participants with dementia at 3 and 9 months were self-reported self-efficacy (Generalised SelfEfficacy Scale), 24 mood (Hospital Anxiety and Depression Scale), 25 and dementia-specific health-related quality of life (DEMQOL). 26 Participants also completed a brief cognitive test battery covering memory (story recall from the Rivermead Behavioural Memory Test), 27 attention (elevator counting and elevator counting with distraction subtests from the Test of Everyday Attention), 28 and executive function (verbal letter fluency from the Delis-Kaplan Executive Function System). 29 Secondary outcomes for study partners at 3 and 9 months were self-reported stress (Relatives' Stress Scale), 30 quality of life (WHOQOL-BREF), 31 and health-related quality of life (EQ 5D). Missing data were addressed through multiple imputation of missing values using a predictive mean matching algorithm. 33 Missing outcome measure scores at baseline were imputed using centre-level factors and the participant's gender, age, and baseline MMSE score. Missing outcome measure scores at the 3-and 9-month assessments were estimated based on centre-level factors, baseline characteristics, and scores for the same outcome at the earlier time-point(s). In line with simulation-based observations of the D2 statistic's performance for pooling P values, 34 25 sets of imputations were generated using the method described above. For both primary and secondary outcomes, the analysis was a mixed-effects analysis of covariance (ANCOVA) adjusted for baseline score, allocation group, and the stratification variables (age group, gender, MMSE score, and centre). Baseline score, allocation group, age group, gender, and MMSE score were treated as fixed effects and centre as a random effect. Between-group effect sizes with confidence intervals (CIs) were calculated using Cohen d (the mean difference between the two arms, divided by the pooled standard deviation). For the primary outcome measure, prespecified regression modelling was undertaken to identify potential effect-modifying factors, selected on clinical and theoretical grounds.
Prespecified exploratory analyses, not adjusted for multiple comparisons, examined the impact of the number of sessions received on primary and secondary outcomes at 3-and 9-month follow-up and investigated whether participants' baseline ratings of goal importance and readiness to change were associated with outcomes.
Sensitivity analyses compared the outcomes of analyses that included both imputed and complete case data with the outcomes of analyses that included complete cases only. An analysis based on treatment received irrespective of group allocation was planned, but proved unnecessary as group allocation and treatment received were 100% consistent.
Interviews were conducted with a consecutive series of participants and study partners completing the intervention in three of the trial sites by an interviewer independent of the trial. Interviews but will be reported more fully in a separate paper.
| Patient and public involvement
Alzheimer's Society Research Network volunteers contributed to development of the trial protocol and served as experts by experience on the Trial Steering Committee (TSC).
| Changes to protocol
The trial was initially set up with six sites, but two further sites were added to ensure recruitment targets were met. Interviews with a subset of participants and study partners were added on the recommendation of the experts by experience.
| RESULTS
The flow of participants through the trial is shown in Figure 1 .
Following baseline assessment, 475 participants were randomised to either CR (n = 239) or TAU (n = 236). One participant who did not meet diagnostic criteria was incorrectly randomised and was withdrawn from analysis. All participants received their allocated condition, and 90% of CR participants completed at least 10 sessions.
Six participants in the CR group withdrew from the intervention after at least two sessions but remained in the trial to complete follow-up assessments. Retention in the trial was 94% at 3 months and 90% at 9 months. Of 36 couples invited to participate in an interview following the 9-month follow-up, 26 agreed, although in one case only the study partner completed the interview.
| Sample characteristics
Demographic and clinical characteristics of the participants with dementia and study partners are summarised in Table 1 . There were 111 serious adverse events reported during the trial, affecting 68 participants and 26 study partners and mostly involving hospitalisation;
blinded assessors judged that none were related to trial participation.
| Numbers analysed
The intention to treat analysis included data from 474 participants at baseline (CR n = 238; TAU n = 236), 445 participants at 3 months (CR n = 218; TAU n = 227), and 426 participants at 9 months (CR n = 208; TAU n = 218).
| Main outcome analyses
The primary outcome was participants' goal attainment ratings on the BGSI at 3 months. Participant attainment and satisfaction ratings and study partner attainment ratings across all time points, and details of the statistical analyses, are summarised in Table 2 . According to these participant-reported outcomes, CR was effective in improving functioning in the targeted areas at 3 months from the perspective of both participants and study partners, and this improvement was maintained at 9 months. Note that the analyses reported in Table 2 cover all goals that were identified at baseline, and for the CR group, this included a number of goals that were not addressed in the intervention. The CR group participants identified 679 goals and worked on 481 (71%) of these with the therapists. Taking just the 481 goals that were addressed in therapy, the mean change in participants' goal attainment ratings was an improvement of 2.84 points (SD 2.84) at 3 months and 2.77 points (SD 3.18) at 9 months, while study partners' ratings showed an improvement of 3.09 points (SD 2.73) at 3 months and 2.76 points (SD 3.14) at 9 months.
For the primary outcome measure at 3 months, linear mixedeffects models examining participant (centre, MMSE score, diagnosis, medication use, education, socio-economic status, and blinding effectiveness) and study partner (centre, gender, age, education, hours spent helping the participant, and type of relationship with the participant) factors predicting change in participants' goal attainment ratings from baseline to follow-up in the CR group were not statistically significant apart from socio-economic status, where higher socioeconomic status was associated with better outcomes; see Supporting
Information Table S1 . Participants' baseline ratings of the importance of each goal did not predict improvement. Ratings of readiness to change in relation to the goal were significantly associated with improvement in attainment ratings (t 403 = 2.66, r = 0.13, P = 0.008), as was adherence, defined as number of CR sessions completed (b = 0.17; SE = 0.09; t 215 = 2.01; P = 0.046; 95% CI, 0-0.34).
Scores on secondary outcome measures at all time-points, and ANCOVA analyses, are presented in Table 3 . Following Bonferroni correction, there were no significant differences. Effect sizes were small to negligible, although in some cases with wide confidence intervals.
| Sensitivity analyses
Results from the analysis of complete case data were very similar to those of the multiple imputation analysis and did not alter the pattern of findings; see Tables S2 and S3 . The difference in attrition between CR and TAU was minimal, and no statistically significant differences were observed in baseline characteristics or in primary and secondary outcomes for participants who withdrew and remained in the study;
see Tables S4 and S5 . Consequently, multiple imputation did not need to be modified.
| Qualitative evaluation
Participants and study partners who were interviewed after completing the trial responded positively to the intervention, although for some study partners this was tempered by the knowledge that dementia would continue to progress. Participants and study partners valued the relationship with the therapist, both for the specific focus on developing and personalising strategies and for the more general information and support provided. Interviewees said that at 3 months, and this improvement was maintained at 9 months. When considering the goals actually addressed in therapy, improvements met criteria for clinical significance. High levels of adherence and low attrition indicated that the intervention was acceptable to participants and study partners. Participants and study partners interviewed in depth viewed the intervention positively and felt that it was beneficial.
| Strengths and limitations
A key strength is that the intervention targeted real-life situations and aimed to improve participants' functioning in areas that were meaningful to them, avoiding any problems relating to lack of transfer or generalisation of effects. The primary outcome was a proximal measure, directly evaluating perceptions of change in the areas targeted in the intervention. No trial-related adverse events or harms were identified.
There are several limitations to consider. Due to the constraints of trial design, the goal-setting interview was conducted by researchers not involved in delivering therapy, whereas in clinical practice, the goal-setting process would be undertaken by the therapist and might be more efficient. While participants were invited to select up to three goals, on average, the therapists were able to address two goals per participant. The primary outcome was based on ratings of progress with all goals identified at baseline, rather than just those goals that were actually addressed; therefore, the overall estimate of improvement in goal attainment is a conservative one. Ratings for the goals that were directly addressed showed a clinically meaningful degree of change. The trial design did not allow us to conclusively demonstrate that benefits were due to the specific effects of CR rather than nonspecific effects of contact with a therapist; however, the observed gains related specifically to improvements in functional ability for goals directly targeted in the therapy, and in the pilot trial, CR demonstrated benefits over an active control condition. In selecting secondary outcome measures, it would have been useful to include a measure of functional ability.
| How the findings relate to other evidence
The results confirm the finding from our pilot trial 13 that CR is effective in improving those aspects of everyday functioning targeted in the intervention. A different, but related, approach to improving everyday functioning involves structured training in completing selected activities of daily living. Two recent trials 35, 36 found that performance on trained tasks improved, although there was no evidence of generalisation to everyday situations 35 or improvement in secondary outcomes such as quality of life. The only other large-scale trial Nineteen adjustments in total to adjust for all the participant and carer outcome measure comparisons, except for the primary outcome.
d ANCOVA adjusted for baseline score, allocation group and stratification variables, age, gender, MMSE score and site. CI, confidence intervals. The d effect size estimates were based on a fixed effect size model as they cannot be derived directly from the mixed-effects model and were calculated by converting eta squared to r, and then converting r to d. of CR 37 reported that, compared with usual treatment, CR participants showed less functional decline at 24 months, a 6-month delay in institutionalisation and lower overall rates of institutionalisation, but no significant differences mood or quality of life. The CR intervention in that trial was poorly described, and goal attainment was not directly measured.
These findings taken together indicate that it is possible to promote improved functional ability through both CR and structured training. In CR, this improvement directly benefits targeted areas of everyday life, whereas the improvements observed following structured task-specific training may not generalise to real-life situations.
Other benefits resulting from CR or structured training are not captured by available standardised outcome measures. In GREAT, there are several possible explanations for the lack of change in secondary outcomes. The finding of no differences in cognitive test scores was unsurprising as the intervention does not directly seek to improve cognitive function. As only a small proportion of participants reported clinical levels of depression or anxiety at baseline, there was little scope for the intervention to demonstrate improvements in these domains. The absence of reduction in stress for study partners might be explained by the fact that the intervention did require effort from them, both to engage when they may feel they have already tried various strategies without success and to support the implementation of strategies through the therapy. However, the qualitative findings were at odds with the results from secondary outcome measures. The intervention may therefore have provided wider benefits that were not detected by available standardised measures.
| Implications
The study shows that people with dementia are able to identify key goals and are motivated to address them. Readiness to make changes in these areas predicts outcome and is an important factor for practitioners to consider at initial assessment. However, only those Twenty adjustments in total to adjust for all the participant and carer outcome measure comparisons.
